Atlas Venture Opportunity Fund II, L.P.'s Net Worth

$27.1 Million

Estimate Recalculated Nov 11, 2024 01:52PM EST

Who is Atlas Venture Opportunity Fund II, L.P.

Atlas Venture Opportunity Fund II, L.P. has an estimated net worth of $27.1 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., Disc Medicine, Inc., Dyne Therapeutics, Inc., Korro Bio, Inc., and Homology Medicines, Inc..

SEC CIK

Atlas Venture Opportunity Fund II, L.P.'s CIK is 0001885327

Past Insider Trading and Trends

2022 was Atlas Venture Opportunity Fund II, L.P.'s most active year for acquiring shares with 2 total transactions. Atlas Venture Opportunity Fund II, L.P.'s most active month to acquire stocks was the month of March. 2022 saw Atlas Venture Opportunity Fund II, L.P. paying a total of $21,500,021.70 for 1,701,248 shares, this is the most they've acquired in one year.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Day One Biopharmaceuticals, Inc.

Investor
Updated Jun 22, 2022
Form 4
766.67K
$15.00
$11.50M
Jun 22, 2022
8.98M
Purchase
Jun 17
Showing 1 results

Dyne Therapeutics, Inc.

Investor
Updated Mar 05, 2024
Form 4
-1.98%
-46.53K
$30.05
-$1.40M
Mar 05, 2024
2.31M
Sale
ScheduledMar 01
Form 4
-5.89%
-807.84K
$24.32
-$19.63M
Feb 28, 2024
12.90M
Sale
ScheduledFeb 26 - Feb 28
Form 4
-5.35%
-500.79K
$22.68
-$11.34M
Feb 23, 2024
8.86M
Sale
ScheduledFeb 21 - Feb 23
Form 4
934.58K
$10.70
$10.00M
Dec 14, 2022
9.87M
Purchase
Dec 12
Showing 4 results

Korro Bio, Inc.

Investor
Updated Apr 23, 2024
Form 4
10.08%
17.86K
$56.00
$999.99K
Apr 23, 2024
195.07K
Purchase
Apr 22
Form 3
Nov 07, 2023
1.12M
Showing 2 results

Disc Medicine, Inc.

Investor
Updated Jan 25, 2024
Form 4
-6.11%
-150.00K
$67.65
-$10.15M
Jan 25, 2024
2.30M
Sale
Jan 23
Form 3
Jan 03, 2023
218.33K
Showing 2 results

Homology Medicines, Inc.

Investor
Updated Mar 27, 2024
Form 3
Mar 27, 2024
2.09M
Showing 1 results